Bio-Bridge Science to Present at Rodman & Renshaw 11th Annual Healthcare Conference on September 11
September 03 2009 - 8:17AM
Business Wire
Bio-Bridge Science, Inc. (OTCBB:BGES), a biotechnology company
focused on the commercial development of biological products for
the prevention and treatment of human diseases, and production
materials used in producing vaccines, announced today that Dr.
Liang Qiao, the Company’s chief executive officer, will present at
the Rodman & Renshaw 11th Annual Healthcare Conference, on
Friday, September 11, 2009, at 1:10 p.m. Eastern time in the
Spellman Salon on the 5th floor of the Palace Hotel, New York
City.
The presentation will give an overview of the Company, a summary
of its strategic plan, as well as, discuss recent events.
This press release contains forward-looking statements.
Forward-looking statements include statements concerning plans,
objectives, goals, strategies, future events or performance, and
underlying assumptions and other statements that are other than
statements of historical facts. These statements are subject to
uncertainties and risks including, but not limited to, product and
service demand and acceptance, changes in technology, economic
conditions, the impact of competition and pricing, government
regulation, and other risks defined in this document and in
statements filed from time to time with the Securities and Exchange
Commission. All such forward-looking statements, whether written or
oral, and whether made by or on behalf of the company, are
expressly qualified by these cautionary statements and any other
cautionary statements which may accompany the forward-looking
statements. In addition, the company disclaims any obligation to
update any forward-looking statements to reflect events or
circumstances after the date hereof. Please refer to the Company's
SEC filings for additional information.
Bio Bridge Science (CE) (USOTC:BGES)
Historical Stock Chart
From Jun 2024 to Jul 2024
Bio Bridge Science (CE) (USOTC:BGES)
Historical Stock Chart
From Jul 2023 to Jul 2024
Real-Time news about Bio Bridge Science Inc (CE) (OTCMarkets): 0 recent articles
More Bio-Bridge Science, Inc. News Articles